Hosted on MSN10mon
For Advanced Bladder Cancer, The Drug Balversa Is Now FDA Approved– A Promising Therapy For People With Specific Mutations
The U.S. Food and Drug Administration (FDA) has now approved the drug Balversa (which has the molecular name erdafitinib) for the treatment of metastatic bladder cancer with a specific genetic ...
Several multinational pharmaceuticals launch multiple new drugs in China amid policy boost
Several foreign drugmakers have announced debuts for their new drugs in the Chinese market since the beginning of 2025, as ...
Hosted on MSN1mon
Novel bladder cancer treatment gains MHRA approval in the UK
Today’s authorization of erdafitinib, a targeted therapy that has been shown to significantly improve overall and progression-free survival for patients with FGFR3 alterations, will come as ...